GLENMEDE TRUST CO NA - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$2,636
-79.1%
20,0000.0%0.00%
Q2 2023$12,6000.0%20,0000.0%0.00%
Q1 2023$12,600
-2.9%
20,0000.0%0.00%
Q4 2022$12,982
-61.8%
20,0000.0%0.00%
Q3 2022$34,000
+41.7%
20,0000.0%0.00%
Q2 2022$24,000
+84.6%
20,000
-2.9%
0.00%
Q1 2022$13,000
-40.9%
20,6060.0%0.00%
Q4 2021$22,000
-40.5%
20,6060.0%0.00%
Q3 2021$37,000
-28.8%
20,606
+3.0%
0.00%
Q2 2021$52,000
+2500.0%
20,000
+2122.2%
0.00%
Q2 2020$2,0000.0%900
+42.0%
0.00%
Q2 2014$2,0000.0%6340.0%0.00%
Q1 2014$2,0000.0%6340.0%0.00%
Q4 2013$2,0006340.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders